| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8230627 | International Journal of Radiation Oncology*Biology*Physics | 2011 | 6 Pages |
Abstract
Statin use during high-dose RT for clinically localized prostate cancer was associated with a significant improvement in PRFS in high-risk patients. These data suggest that statins have anticancer activity and possibly provide radiosensitization when used in conjunction with RT in the treatment of prostate cancer.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Marisa A. M.D., Matthew S. M.D., Kimberley Mak, Yoshiya M.D., F.R.C.P.C., David J. B.A., Zhigang Ph.D., Xiaoyu M.S., Weiji M.S., Michael J. M.D.,